Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
about
Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigenAberrant glycosylation as biomarker for cancer: focus on CD43.Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody.Serine versus threonine glycosylation with α-O-GalNAc: unexpected selectivity in their molecular recognition with lectins.Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate.Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells.
P2860
Q36497647-50C62D00-29AC-485A-8FBD-EA0448AEF4BEQ36654041-FBF10A53-3B46-4975-BC39-304BD71E45C9Q37222147-726F59E9-7BFF-4299-B51A-F1AC3E1852A3Q37618865-7CD44064-0A2E-4FF2-A956-6594B2C43E0FQ38203883-10FA18F4-7A56-4B7D-AD79-B19CEFCB6D6AQ38869978-CE6EA2CF-BBCE-4AF3-A4C8-3668857295B7Q40789473-4D487D25-93A5-4398-BACF-8D2D734408EFQ43856190-DFD45BD6-6C35-4BA9-B3DE-528A09AEDE5FQ46024099-1862F65B-D2FF-4909-B47D-7972F9122393Q47902181-E9F84E29-1D2E-43EB-A2FA-A86BA3160491Q48169265-AB79A0C3-4C94-4073-85D0-BC4336A8E187Q48246161-7A359B91-125C-4F66-A13E-6EB3145EB9CAQ51051666-3AC6D150-9344-4B94-964B-F067D6D12BC8
P2860
Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Monoclonal antibodies toward d ...... ve immuno-targeting of cancer.
@en
Monoclonal antibodies toward d ...... ve immuno-targeting of cancer.
@nl
type
label
Monoclonal antibodies toward d ...... ve immuno-targeting of cancer.
@en
Monoclonal antibodies toward d ...... ve immuno-targeting of cancer.
@nl
prefLabel
Monoclonal antibodies toward d ...... ve immuno-targeting of cancer.
@en
Monoclonal antibodies toward d ...... ve immuno-targeting of cancer.
@nl
P2093
P2860
P1476
Monoclonal antibodies toward d ...... ive immuno-targeting of cancer
@en
P2093
Andrea Medeiros
Christelle Ganneau
Claude Leclerc
Daniel Mazal
Edith Dériaud
Eduardo Osinaga
Gonzalo Obal
Luis Ubillos
Nora Berois
Otto Pritsch
P2860
P2888
P304
P356
10.1007/S00262-013-1425-7
P577
2013-04-21T00:00:00Z